/PRNewswire/ --Pharmacyclics, Inc. today announced the initiation of PCYC-1136-CA, a multi-center study that will investigate the use of ibrutinib... ...http://in.advfn.com/p.php?pid=nmona&article=67053537
/PRNewswire/ -- Prometheus Laboratories, Inc. announced today the presentation of data from patients enrolled in the PROCLAIM SM national patient... ...http://in.advfn.com/p.php?pid=nmona&article=67052210
Comments May 28, 2015 - NEW YORK, NY NEW YORK, NY--(Marketwired - May 28, 2015) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or... ...http://andhranews.net/Business/2015/Actinium-Clinical-Update-Actimab-A-Provided-Targeted-21328.htm
GlobeNewswire 2015-05-27 -- MGD006 Enables T Cells to Recognize and Kill Leukemia Cells -- Research Paved the Way for Human Clinical... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=72725
GlobeNewswire 2015-05-27 Immunotherapy Thought Leaders to Discuss Next Wave of Therapies Aimed at Increasing the Number of Patients That... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=72709
CANCER HEALER CENTER is a cancer...